Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Miura, T.; Miki, T.
    GSK-3beta, a therapeutic target for cardiomyocyte protection (2009), Circ. J., 73, 1184-1192.
    View publication on PubMed

Inhibitors

EC Number Inhibitors Comment Organism Structure
2.7.11.26 lithium chloride
-
Rattus norvegicus

Organism

EC Number Organism UniProt Comment Textmining
2.7.11.26 Rattus norvegicus
-
-
-

Posttranslational Modification

EC Number Posttranslational Modification Comment Organism
2.7.11.26 phosphoprotein phosphorylation of GSK-3beta at Ser9 reduces activity of this kinase Rattus norvegicus

Source Tissue

EC Number Source Tissue Comment Organism Textmining
2.7.11.26 cardiomyocyte
-
Rattus norvegicus
-

Substrates and Products (Substrate)

EC Number Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
2.7.11.26 ATP + p53
-
Rattus norvegicus ADP + phosphorylated p53
-
?

Synonyms

EC Number Synonyms Comment Organism
2.7.11.26 glycogen synthase kinase-3beta
-
Rattus norvegicus
2.7.11.26 GSK-3beta
-
Rattus norvegicus

Cofactor

EC Number Cofactor Comment Organism Structure
2.7.11.26 ATP
-
Rattus norvegicus

General Information

EC Number General Information Comment Organism
2.7.11.26 physiological function GSK-3beta is a multifunctional Ser/Thr kinase that plays important roles in necrosis and apoptosis of cardiomyocytes Rattus norvegicus